Sample handling for mass spectrometric proteomic investigations of human sera

被引:109
作者
West-Hielsen, M
Hogdall, EV
Marchiori, E
Hogdall, CK
Schou, C
Heegaard, NHH [1 ]
机构
[1] Statens Serum Inst, Dept Autoimmunol, DK-2300 Copenhagen, Denmark
[2] Danish Canc Soc, Inst Canc Epidemiol, Dept Virus Hormones & Canc, DK-2100 Copenhagen, Denmark
[3] Free Univ Amsterdam, Dept Comp Sci, NL-1081 HV Amsterdam, Netherlands
[4] Rigshosp, Julia Marie Ctr, Gynecol Clin, DK-2100 Copenhagen, Denmark
关键词
D O I
10.1021/ac050253g
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Proteomic investigations of sera are potentially of value for diagnosis, prognosis, choice of therapy, and disease activity assessment by virtue of discovering new biomarkers and biomarker patterns. Much debate focuses on the biological relevance and the need for identification of such biomarkers while less effort has been invested in devising standard procedures for sample preparation and storage in relation to model building based on complex sets of mass spectrometric (MS) data. Thus, development of standardized methods for collection and storage of patient samples together with standards for transportation and handling of samples are needed. This requires knowledge about how sample processing affects MS-based proteome analyses and thereby how nonbiological biased classification errors are avoided. In this study, we characterize the effects of sample handling, including clotting conditions, storage temperature, storage time, and freeze/thaw cycles, on MS-based proteomics of human serum by using principal components analysis, support vector machine learning, and clustering methods based on genetic algorithms as class modeling and prediction methods. Using spiking to artificially create differentiable sample groups, this integrated approach yields data that - even when working with sample groups that differ more than may be expected in biological studies -clearly demonstrate the need for comparable sampling conditions for samples used for modeling and for the samples that are going into the test set group. Also, the study emphasizes the difference between class prediction and class comparison studies as well as the advantages and disadvantages of different modeling methods.
引用
收藏
页码:5114 / 5123
页数:10
相关论文
共 32 条
[1]  
Adam BL, 2001, PROTEOMICS, V1, P1264, DOI 10.1002/1615-9861(200110)1:10<1264::AID-PROT1264>3.0.CO
[2]  
2-R
[3]   Ovarian cancer detection by logical analysis of proteomic data [J].
Alexe, G ;
Alexe, S ;
Liotta, LA ;
Petricoin, E ;
Reiss, M ;
Hammer, PL .
PROTEOMICS, 2004, 4 (03) :766-783
[4]   Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments [J].
Baggerly, KA ;
Morris, JS ;
Coombes, KR .
BIOINFORMATICS, 2004, 20 (05) :777-U710
[5]   A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease [J].
Carrette, O ;
Demalte, I ;
Scherl, A ;
Yalkinoglu, O ;
Corthals, G ;
Burkhard, P ;
Hochstrasser, DF ;
Sanchez, JC .
PROTEOMICS, 2003, 3 (08) :1486-1494
[6]   Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization [J].
Coombes, KR ;
Fritsche, HA ;
Clarke, C ;
Chen, JN ;
Baggerly, KA ;
Morris, JS ;
Xiao, LC ;
Hung, MC ;
Kuerer, HM .
CLINICAL CHEMISTRY, 2003, 49 (10) :1615-1623
[7]   Multifactorial screening design and analysis of SELDI-TOF ProteinChip® array optimization experiments [J].
Cordingley, HC ;
Robets, SLL ;
Tooke, P ;
Armitage, JR ;
Lane, PW ;
Wu, W ;
Wildsmith, SE .
BIOTECHNIQUES, 2003, 34 (02) :364-+
[8]  
Cristiannini N., 2000, SUPPORT VECTOR MACHI
[9]   Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems [J].
Diamandis, EP .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (05) :353-356
[10]   Point - Proteomic patterns in biological fluids: Do they represent the future of cancer diagnostics? [J].
Diamandis, EP .
CLINICAL CHEMISTRY, 2003, 49 (08) :1272-1275